DEXTER Robotic Surgery System
Simplified robotic surgery system enabling access across more sites of care
Device · On PremiseCompany source
Company profile
About Distalmotion
Distalmotion is a Swiss medical robotics company dedicated to empowering access to the benefits of robotic surgery. The company develops the DEXTER Robotic Surgery System, which uniquely simplifies surgical operations to enable more surgeons in more operating rooms to provide the benefits of robotics to more patients. By removing operational barriers to surgical robotics, Distalmotion aims to ensure that more surgeons in more sites of care can provide patients with best-in-class minimally invasive surgery. Founded in 2012 as a spin-off from the Robotics Lab of the Swiss Federal Institute of Technology in Lausanne (EPFL), Distalmotion developed DEXTER in collaboration with expert teaching centers and clinicians. The system received CE mark approval in 2020 for Urology, Gynecology, and General Surgery procedures. In the United States, DEXTER is cleared for adult inguinal hernia repair, cholecystectomy, total benign hysterectomy, oophorectomy, salpingectomy, and combinations of these procedures. The system performed its first clinical cases in 2021 and is now treating patients daily. DEXTER integrates into existing surgical workflows while maintaining surgeon-patient connection and compatibility with preferred technologies, making it particularly suitable for outpatient facilities and diverse care settings.
Company description Distalmotion official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Distalmotion?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Benign hysterectomy
- Cholecystectomy (gallbladder removal)
- General surgery procedures
- Gynecological procedures
- Inguinal hernia
- Oophorectomy
- Salpingectomy
- Urological procedures
Who it serves
- Health Systems
- Hospitals
- Outpatient surgical facilities
- Surgeons
Deployment & integration
On Premise deployment with recorded integration context.
Geographic context
MarketsEurope · Switzerland · United States
Company sourceOfficial website
Company milestones
Platform expansion
First clinical cases performed in 2021, system now treating patients daily across multiple sites
Partnerships
Recorded partners
- Expert teaching centers and clinicians
- Swiss Federal Institute of Technology in Lausanne (EPFL)
- University at Buffalo Jacobs School of Medicine & Biomedical Sciences
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Robotic-assisted cholecystectomy with DEXTER®: the first prospective multicenter study.Surgical endoscopy · Dec 1, 2025
Multicenter evaluation of the DEXTER® Robotic Surgery System for Total Hysterectomy with Adnexal Surgery.Journal of robotic surgery · Sep 26, 2025
Expanding Robotic-Assisted Surgery in Gynecology Using the Potential of an Advanced Robotic System.Medicina (Kaunas, Lithuania) · Dec 27, 2023
Clinical validation
Clinical-trial records
Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic SystemNCT07746531 · Sponsor · NOT YET RECRUITING
Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic SystemNCT07181876 · Sponsor · RECRUITING
Hysterectomy With Adnexal Surgery Procedures With the DEXTER Robotic System (The HYPER Study)NCT06473675 · Sponsor · COMPLETED
Robotic Sacrocolpopexy and Sacrocervicopexy - an Observational Study to Confirm the Peri- and Postoperative Safety and Clinical PerformanceNCT07031050 · Sponsor · COMPLETED
Robotic Assisted Right Colectomy With the DEXTER Robotic Surgery SystemNCT07123051 · Sponsor · RECRUITING
Robotic Minimally Invasive Ventral Hernia Repair With DEXTERNCT07071740 · Sponsor · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Operational simplification
Enables robotic surgery programs in outpatient facilities without disrupting existing workflows
Expanded access
Allows more surgeons in more ORs to provide benefits of robotics to more patients
University at Buffalo Jacobs School of Medicine & Biomedical Sciences
Setting up a robotics program in outpatient facility without disrupting existing workflows
Enabled more surgeons to expand their capabilities in outpatient setting
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Steven Schwaitzberg
MD, Chairman of the Department of Surgery
06 · Company updates
Updates from Distalmotion
Recent articles published on Distalmotion's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.